MiNK Therapeutics, Inc.
(NASDAQ : INKT)

( )
INKT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.93%54.040.9%$1956.39m
JNJJohnson & Johnson -0.82%165.210.7%$952.05m
ABBVAbbVie, Inc. -1.62%133.021.9%$896.21m
MRKMerck & Co., Inc. -0.69%80.730.7%$844.40m
BMYBristol-Myers Squibb Co. -0.17%64.611.0%$686.91m
LLYEli Lilly & Co. -0.76%243.201.1%$618.39m
AZNAstraZeneca Plc 1.16%60.171.0%$237.52m
NVSNovartis AG -0.75%88.180.2%$191.03m
GSKGlaxoSmithKline Plc -1.77%44.880.2%$165.07m
NVONovo Nordisk A/S -1.86%95.480.1%$149.54m
VTRSViatris, Inc. -0.54%14.640.0%$136.21m
RGENRepligen Corp. -0.59%188.466.7%$100.63m
ALLKAllakos, Inc. -3.37%7.180.0%$85.67m
IMMXImmix Biopharma, Inc. -4.24%5.420.0%$85.35m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.87%116.040.0%$75.90m

Company Profile

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.